• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Altria Announces Intent to Sell a Portion of its Investment in Anheuser-Busch InBev

    3/13/24 4:15:00 PM ET
    $BUD
    $MO
    Beverages (Production/Distribution)
    Consumer Staples
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BUD alert in real time by email

    Altria Group, Inc. (Altria) (NYSE:MO) today announced its intent to sell a portion of its investment in Anheuser-Busch InBev SA/NA (ABI) (NYSE:BUD) (Euronext: ABI) (MEXBOL: ANB) (JSE: ANH) through a global secondary offering (offering) comprised of a public offering of ABI ordinary shares represented by American depositary shares (ADS) in the United States, a public offering of ABI ordinary shares in the United States, a concurrent private placement of ABI ordinary shares in the European Economic Area and the United Kingdom and an offering of ABI ordinary shares, including ABI ordinary shares represented by ADSs, in other countries outside the United States. In addition, ABI has agreed to repurchase $200 million of ordinary shares directly from Altria, concurrently with, and conditional on, completion of the offering.

    Altria currently holds approximately 197 million shares of ABI, representing approximately 10% ownership. Altria, as the selling shareholder, is offering 35 million of ABI's ordinary shares. In connection with the offering, Altria expects to grant the underwriters an option to purchase up to 5.25 million additional ABI shares owned by Altria, exercisable within 30 days following the pricing of the offering. In addition, we have agreed to a 180-day lockup with the lead underwriter for our remaining ABI shares.

    We expect to use the proceeds for additional share repurchases of our common stock. Future share repurchases remain subject to the discretion of our Board of Directors (Board).

    "As good stewards of shareholder capital, we consistently review options to unlock the value of our ABI investment, and we believe this is an opportunistic transaction that realizes a portion of the substantial return on our long-term investment," said Billy Gifford, Altria's Chief Executive Officer. "Over the decades of our ownership, the beer investment has provided significant income and cash returns and supported our strong balance sheet. Our continued investment reflects ongoing confidence in ABI's long-term strategies, premium global brands and experienced management team."

    The offering and the partial sale of our investment in ABI have been approved by our Board.

    ABI has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission (SEC) for the offering to which this release relates. Before you invest, you should read the prospectus in that registration statement and other documents ABI has filed with the SEC, including the preliminary prospectus supplement dated March 13, 2024, for more complete information about ABI and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the prospectus supplement, when available, if you request them by contacting: Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attn: Prospectus Department; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 866-803-9204 or by email at [email protected].

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    Morgan Stanley is acting as the lead underwriter for the proposed offering. J.P. Morgan is also acting as an active underwriter for the proposed offering.

    Forward-Looking and Cautionary Statements

    This release contains certain forward-looking statements with respect to the offering, which are subject to various risks and uncertainties. These forward-looking statements relate to, among other things, the anticipated completion of the offering and our intended use of proceeds. Factors that may cause actual results to differ include prevailing economic, market or business conditions or changes in such conditions. Other risk factors are detailed from time to time in our publicly filed reports, including our Annual Report on Form 10-K for the year ended December 31, 2023. These forward-looking statements speak only as of the date of this release. We assume no obligations to provide any revisions to, or update, any forward-looking statements contained in or implied by this release.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240313927448/en/

    Get the next $BUD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BUD
    $MO

    CompanyDatePrice TargetRatingAnalyst
    Altria Group Inc.
    $MO
    1/9/2026$63.00Neutral → Buy
    UBS
    Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
    $BUD
    11/28/2025Buy → Hold
    Deutsche Bank
    Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
    $BUD
    11/19/2025$75.00Overweight
    Wells Fargo
    Altria Group Inc.
    $MO
    7/9/2025$50.00Underperform
    Jefferies
    Altria Group Inc.
    $MO
    7/2/2025$59.00Sell → Neutral
    UBS
    Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
    $BUD
    5/12/2025$88.00Neutral → Buy
    Goldman
    Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
    $BUD
    4/2/2025Buy
    Berenberg
    Altria Group Inc.
    $MO
    4/1/2025Buy → Hold
    Deutsche Bank
    More analyst ratings

    $BUD
    $MO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Davis Robert Matthews bought $48,599 worth of shares (1,200 units at $40.50), increasing direct ownership by 16% to 8,473 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:08:44 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Clarke Ian L.T. bought $44,625 worth of shares (1,100 units at $40.57), increasing direct ownership by 18% to 7,145 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:03:21 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BUD
    $MO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Budweiser Honors 40 Years of FIFA World Cup™ Legacy with Limited-Edition Collectible Pack and Nostalgia-Themed Platform

    The iconic brand marks its return as the Official Beer Sponsor of FIFA World Cup™ with anniversary packaging, a global film, and creative billboard tributes to football's greatest moments Today, Budweiser is celebrating 40 years as the Official Beer Sponsor of the FIFA World Cup™ with the launch of the largest limited-edition collectible pack ever – the Budweiser® FIFA World Cup™ Anniversary Pack* – bringing to life 11 bold design tributes to every tournament since 1986, and the centerpiece of a new nostalgia driven global platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260407304059/en/Budweiser® FIFA World Cup™ Anniv

    4/7/26 3:00:00 AM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    on! PLUS™ Expands Nationwide Retail Availability

    Altria Group, Inc. (Altria) (NYSE:MO) today announced the national retail expansion of on! PLUS™ nicotine pouches, a next-generation oral nicotine pouch product manufactured by Helix Innovations LLC (Helix), an Altria operating company. "The national expansion of on! PLUS is an exciting milestone for Helix and a meaningful step forward in Altria's Vision of Moving Beyond Smoking®. As adult consumers continue to seek smoke‑free alternatives, on! PLUS reflects our focus on quality, innovation, and responsibly meeting demand within science‑based regulatory frameworks," said Nick MacPhee, Managing Director, Helix. on! PLUS is the first product authorized through the U.S. Food and Drug Admin

    3/23/26 3:30:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Declares Regular Quarterly Dividend of $1.06 Per Share

    Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.06 per share, payable on April 30, 2026 to shareholders of record as of March 25, 2026. The ex-dividend date is March 25, 2026. View source version on businesswire.com: https://www.businesswire.com/news/home/20260225648687/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

    2/26/26 1:00:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BUD
    $MO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief HR Off. & CCO Whitaker Charles N. sold $1,885,718 worth of shares (27,908 units at $67.57), decreasing direct ownership by 13% to 180,869 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    3/9/26 2:38:41 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    EVP & General Counsel Mccarter Robert A. Iii was granted 5,767 shares and covered exercise/tax liability with 4,517 shares, increasing direct ownership by 1% to 123,612 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    3/2/26 3:47:47 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Executive Officer Gifford William F. Jr. was granted 70,364 shares and covered exercise/tax liability with 61,849 shares, increasing direct ownership by 1% to 681,942 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    3/2/26 3:47:39 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BUD
    $MO
    SEC Filings

    View All

    SEC Form DEFA14A filed by Altria Group Inc.

    DEFA14A - ALTRIA GROUP, INC. (0000764180) (Filer)

    4/2/26 9:02:06 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEF 14A filed by Altria Group Inc.

    DEF 14A - ALTRIA GROUP, INC. (0000764180) (Filer)

    4/2/26 9:00:30 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    6-K - Anheuser-Busch InBev SA/NV (0001668717) (Filer)

    3/27/26 4:02:01 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    $BUD
    $MO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Altria upgraded by UBS with a new price target

    UBS upgraded Altria from Neutral to Buy and set a new price target of $63.00

    1/9/26 8:23:08 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Anheuser-Busch InBev downgraded by Deutsche Bank

    Deutsche Bank downgraded Anheuser-Busch InBev from Buy to Hold

    11/28/25 7:17:58 AM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    Wells Fargo initiated coverage on Anheuser-Busch InBev with a new price target

    Wells Fargo initiated coverage of Anheuser-Busch InBev with a rating of Overweight and set a new price target of $75.00

    11/19/25 8:56:04 AM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    $BUD
    $MO
    Leadership Updates

    Live Leadership Updates

    View All

    Altria Group, Inc. Announces Retirement of CEO Billy Gifford and Appointment of Sal Mancuso as Successor

    Altria Group, Inc. (Altria) (NYSE:MO) announces today that Billy Gifford, Altria's Chief Executive Officer (CEO), has decided to retire, effective May 14, 2026 at the conclusion of the 2026 Annual Meeting of Shareholders (2026 Annual Meeting). Billy has had a distinguished career of over 30 years with the Altria family of companies and has served as Altria's CEO since 2020. Altria's Board of Directors (Board) has elected Salvatore (Sal) Mancuso to serve as Altria's CEO upon Billy's retirement. To facilitate a smooth transition, Billy plans to serve as a consultant to Altria upon his retirement through at least the end of 2026. Additionally, the Board elected Heather Newman to serve as Altri

    12/11/25 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    AB InBev and International Cricket Council Announce Landmark Global Partnership

    World's Leading Brewer becomes the Official Beer Partner of the ICC The International Cricket Council (ICC) announced AB InBev (Euronext: ABI) (NYSE:BUD) (MEXBOL: ANB) (JSE: ANH), the world's leading brewer, will become the Official Beer Partner for all major ICC tournaments starting in 2026. The partnership will be led by Budweiser 0.0, Budweiser's no-alcohol beer in India, with other ABI mega brands activating in Europe and Africa. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251211250826/en/AB InBev and ICC announce global partnership From attending a match live in-stadium to watching one at a bar or pub with friends, with

    12/11/25 4:31:00 AM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    Corona Cero Brings Golden Moments to the Mountains of Milano Cortina 2026

    First-ever no-alcohol beer sponsor of Olympic Winter Games celebrates "For Every Golden Moment" platform with consumers globally As the 100-day countdown to the Olympic Winter Games continues, and in a year the global Corona brand is celebrating its 100th anniversary, Corona Cero is officially set to bring golden moments to the slopes of Milano Cortina 2026. As the first no-alcohol beer sponsor of the Winter Olympics, the brand is revving up its "For Every Golden Moment" global platform to invite consumers to celebrate every golden moment any time, any season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251105994873/en/Corona

    11/5/25 4:30:00 AM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    $BUD
    $MO
    Financials

    Live finance-specific insights

    View All

    Altria Declares Regular Quarterly Dividend of $1.06 Per Share

    Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.06 per share, payable on April 30, 2026 to shareholders of record as of March 25, 2026. The ex-dividend date is March 25, 2026. View source version on businesswire.com: https://www.businesswire.com/news/home/20260225648687/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

    2/26/26 1:00:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    AB InBev Reports Full Year and Fourth Quarter 2025 Results

    Underlying EPS increased by 6% with continued margin expansion and free cash flow generation of 11.3 billion USD Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211688662/en/Figure 14. Terms and debt repayment schedule as of 31 December 2025 (billion USD) Regulated and inside information1 "Beer plays an important role in bringing people together and creating moments of celebration. In 2025, we executed our strategy, made disciplined capital allocation choices and delivered growth within our outlook for the year, even as we navigated a dynamic consumer envir

    2/12/26 1:01:00 AM ET
    $APO
    $BUD
    Investment Managers
    Finance
    Beverages (Production/Distribution)
    Consumer Staples

    Altria Reports 2025 Fourth-Quarter and Full-Year Results; Provides 2026 Earnings Guidance

    Altria Group, Inc. (NYSE:MO) today reports our 2025 fourth-quarter and full-year business results and provides our guidance for 2026 full-year adjusted diluted earnings per share (EPS). "2025 was a year of continued momentum for Altria, marked by strong financial performance, strategic progress across our smoke-free portfolio, new relationships in support of our long-term growth goals and significant cash returns to shareholders," said Billy Gifford, Altria's Chief Executive Officer. "For the full year, we grew adjusted diluted earnings per share by 4.4% and returned $8 billion to shareholders through dividends and share repurchases combined." "We expect to deliver 2026 full-year adjust

    1/29/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BUD
    $MO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    SC 13D/A - Anheuser-Busch InBev SA/NV (0001668717) (Subject)

    10/1/24 5:20:48 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    SC 13D/A - Anheuser-Busch InBev SA/NV (0001668717) (Subject)

    10/1/24 4:59:00 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    SC 13D/A - Anheuser-Busch InBev SA/NV (0001668717) (Subject)

    6/21/24 4:30:51 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples